The complications associated with the implantation of prosthetic valves and the experimental attempts to graft the mitral valve are described. Because of the disadvantages connected with the use of artificial valves and as the experimental methods of grafting the mitral valve did not prove satisfactory for clinical use, the authors developed a technique for mitral valve replacement using heterologous aortic valves-reinforced by a semirigid Teflon ring-placed above the mitral annulus inside the atrial cavity. The technique of collecting, preparing, and inserting these grafts is described in detail. Using this method, seven patients with mitral incompetence or mitral disease were operated upon between February and April, 1967. One patient died five weeks after the operation from bacterial endocarditis in a period of severe hospital infection with staphylococcus. The other six patients had a very good clinical result immediately after surgery. At the present time they are symptom-free and have normal heart sounds. Clinical and experimental data: are discussed concerning the long-term fate of aortic heterografts in the mitral position.
with the flow through the outflow tract may be another cause of altered cardiodynamics or postoperative arrhythmias. We believe that the papillary muscles and the ventricular wall can both interfere with the mechanism of the prosthesis.
6. Patients with good clinical results after a prosthetic replacement of the mitral valve may still have an impaired haemodynamic condition. Joyner (1966) , using the ultrasound technique, and Judson, Ardaiz, Strach, and Jennings (1964) , Morrow, Clark, Harrison, and Braunwald (1964) , and Starr, Edwards, and Griswold (1962) , performing complete haemodynamic studies in patients with a Starr mitral prosthesis, have shown that a diastolic gradient across the prosthesis is common and that the pulmonary artery pressure, normal at rest, rises during exercise. The cardiac output does not increase substantially after surgery and its increment with exercise is small.
The prosthetic valves, which in no way resemble normal leaflets in structure, perform a passive opening and closing function reasonably well.
Inherent in their design, however, are features precluding an efficiency equal to that of normal leaflets.
To obviate the drawbacks of the prosthetic valves, homografts (Ross, 1962 (Ross, , 1963 (Ross, , 1964 (Ross, , 1967 Barratt-Boyes, 1964 ; Barratt-Boyes, Lowe, Cole, and Kelly, 1965) and heterografts (Binet, Duran, Carpentier, and Langlois, 1965; O'Brien, 1967; O'Brien and Clarebrough, 1966) have been used with success for replacement of the aortic valve.
Attempts to graft the mitral valve have proved more difficult. First, the mitral annulus of the patient with mitral incompetence is too large to admit a mitral graft from a normal human heart. Secondly, it is difficult to adjust the chordae to the correct length during operation, and even more difficult to judge their future required length when the left ventricle becomes smaller after corrective surgery. One of the authors (G. H. W.) has tried to use a mitral homograft for mitral replacement and found the diseased annulus too large to accommodate a human graft. On another two occasions he used mitral heterografts and, although the size was appropriate for the dilated annulus, it was impo6sible to adjust the length of the chordae correctly.
There are only two published reports regarding replacement of the mitral valve with grafts in humans. Murray, Roschlau, and Lougheed (1956) attempted to place an aortic valve segment in the left ventricle without success. Heimbecker, Baird, Lajos, Varga, and Greenwood (1962) sutured an aortic homograft to the left ventricular side of the mitral annulus. The patient died one month later from chest infection.
Although reports of mitral grafting in humans are few, there has been an impressive volume of experimental work performed on animals. Berghuis, Rastelli, Van Vliet, Titus, Swan, and Ellis, (1964) , Hubka, Siska, Brozman, and Holec (1966) , Pappas, Titus, Berghuis, McKenzie, and Ellis (1966) , Rastelli, Berghuis, and Swan (1965) , and Van Vliet, Titus, Berghuis, and Ellis (1965) used mitral valve homotransplants in dogs with few encouraging results. Lower and Shumway (1963) transplanted a homologous pulmonary valve in the mitral annulus, and Lower, Stofer, and Shumway (1961) replaced the mitral valve with an autologous pulmonary valve with better results.
A number of authors (Bigelow, Yao, Aldridge, Heimbecker, and Murray, 1964; Heimbecker et al., 1962; McKenzie, Pappas, Titus, and Ellis, 1966a; Murray et al., 1956; Pappas et al., 1966; Willman, Zafiracopoulos, and Hanlon, 1961) transplanted a homologous aortic valve segment in the mitral area, suturing the base of the transplant to the mitral annulus and the tops of the three commissures inside the left ventricle.
Mackenzie and others (McKenzie, Titus, Ellis, and Pappas, 1965; McKenzie et al., 1966a; McKenzie, Titus, Rastelli, Pappas, and Ellis, 1966b) At this stage the inside diameter of the valve is measured from both the ventricular and the aortic side and the result is recorded. The valve is then placed in cold saline and sent to the tissue bank. The processing technique used is that previously described by Barratt-Boyes (1965) , i.e., sterilization with f8-propiolactone, instant freezing at -80°C., and freezedrying.
PREPARATION OF GRAFT AND TEFLON RING AT TIME OF SURGERY Before operation the size of the aortic graft is selected in relation to the size of the heart and the type of mitral disease present. Grafts with an internal diameter of between 30 and 38 mm. (as measured from the aortic side) are considered sufficient to adapt to any mitral annulus. The selected graft is reconstituted a few hours before operation in saline (containing 50 units/ml. heparin, 100 units/ml. penicillin, and 0-2 gr./l. streptomycin) at a temperature of 400 C. The graft is then ready for attachment to a Teflon ring.
A selection of semi-rigid Teflon rings (3 mm. in thickness and 34 to 40 mm. internal diameter) covered with Teflon cloth have been prepared and sterilized in advance. We have used two types of Teflon ring, both conical in shape, to accommodate well to the shape of the graft. One type, as shown in Fig. 1 , covers only two-fifths of the aortic graft. At the time of surgery it is sutured to the graft by a continuous running suture at the inferior margin and by interrupted stitches at the superior margin. The second type of Teflon ring (which is now preferred) covers the graft completely by having a long sleeve (Fig. 2 ). This type of ring is sutured to the aortic graft by a single row of interrupted stitches at the superior margin. The coronary ostia of the graft are closed by interrupted stitches, whichever type of Teflon ring is used. The diseased mitral valve is excised, leaving a ring of 2 to 3 mm. of valve tissue behind. The aortic graft with its attached Teflon ring is orientated in such a way as to place the largest aortic cusp towards the aortic part of the mitral annulus.
The double needle sutures, which had previously been passed through the aortic wall of the graft and Teflon cloth in the long sleeve rings from the inside, are now taken one by one through the mitral annulus from below, starting from the anterior commissure.
When all the sutures are in place, the graft is lowered in the atrium and the stitches are tied (Fig.  6 ). At this stage, and even before tying the stitches, the valve becomes competent and care must be taken to prevent this.
Once the graft is in its final position, the upper part of the Teflon ring is secured to the atrial wall with a running suture after clearly visualizing the opening of the left lower pulmonary vein (Fig. 7) . The auricular appendage is occluded by a few stitches from inside the atrium and the operation is concluded in the conventional manner (Fig. 8) .
CASE REPORTS
We have inserted aortic heterografts in seven patients between February and April 1967. All the patients were operated upon using a Melrose heart-lung machine, high flow, haemodilution, and mild hypothermia. The perfusion time was between 60 and 90 minutes.
During the whole open-heart procedure the heart was allowed to beat and a vent needle (Groves and Effler, 1964) (a few weeks before the operation the cardiac output was 3-4 1.). The patient had a completely smooth post-operative course, and at the present time he has normal heart sounds and is symptom-free (Fig. 9 ). uneventful. At the present time the patient has normal heart sounds and is asymptomatic.
DISCUSSION
We started work on mitral heterografts in an attempt to obviate the drawbacks and complications connected with the use of entirely artificial mechanisms. The reasons for using a semi-rigid Teflon ring in conjunction with the aortic graft may be summarized as follows: 1. It helps to position such a graft even in an enormously dilated atrium by bringing the atrial wall to the graft instead of allowing the graft to become distorted by the atrium.
2. It maintains the sinuses of Valsalva in an almost normal position. Suturing the graft (which is not a perfectly round structure) to a somewhat smaller Teflon ring puts the commissures under slight tension in the plane of the ring by increasing the radius on the side of the commissures, reducing at the same time the radius of the sinuses of Valsalva (Fig. IOA) . Cuttlng the aortic cuff in a fluted shape (shorter on the commissure side and longer in the middle of the cusps) will produce the same effect, i.e., putting the commissures under slight tension, but in a vertical direction (Fig. lOB) . These will prevent the valve from becoming incompetent.
3. The suture of the upper part of the valve to the atrial wall is greatly facilitated. 4. The mechanical resistance of the aortic cuff is increased, although this part of the graft is reinforced by the atrial wall.
5. The manner of constructing these Teflon rings makes it possible to adjust their shape according to the graft anatomy (by tying one or other of the two threads placed in the ring it can be made more conical or more cylindrical).
The principal questions concerned with the use of aortic grafts in the surgical treatment of mitral valve disease relate to the long-term fate of the graft. In this regard the good clinical results obtained by Ross and Barratt-Boyes with aortic homografts in a sub-coronary position three to five years after the operation, substantiated by follow-up studies done one year after the operation (Davies, Lessof, Roberts, and Ross, 1965) , are most encouraging. Pathological studies performed on aortic homografts by Hudson (1966) give evidence of good acceptance of the graft by the host tissues. Murray et al. (1956) , Murray (1960) , and Beall, Morris, Cooley, and De Bakey (1961) implanted aortic homografts in the descending aorta as a palliation for aortic incompetence with good results. Long-term follow-up studies (Kerwin, Lenkei, and Wilson, 1962) of patients operated on in 1956 by Murray showed no change in valve function. These patients are still alive more than 10 years after the operation.
There is good evidence of acceptance of heterograft valves by the host. Duran and Gunning (1965) proved, by implanting heterografts in the descending aorta of dogs, that the leaflets remain thin and pliable over a period of eight months. Binet et al. (1965) and Carpentier (1967) report a good result with aortic heterografts after 17 months of implantation; O'Brien (1967) and O'Brien and Clarebrough (1966) have good results with aortic heterografts more than one year after operation. It appears from these studies that there is no biological difference between a homograft and a heterograft, their behaviour in humans being almost the same.
There are several advantages in using heterografts, e.g., the available number of grafts is unlimited for all the required sizes; they are taken from young healthy animals and it is possible to have a large size aortic heterograft to accommodate a dilated mitral annulus and an enlarged left auricle. Our good clinical results immediately after surgery, together with the good long-term results reported by others using homoand heterografts in the aortic orifice, are encouraging us to continue in this way.
Post-operative haemodynamic, phonocardiographic, and angiographic investigations are now being performed and the results will be reported soon.
The follow-up period of this group of seven patients is as yet too short to make any statement concerning possible deleterious long-term effects which may arise from using an aortic graft in the mitral position. We do not yet know whether the architecture of the aortic heterograft will change in time, owing to the fact that a structure, functionally adapted to the particular flow and pressure pattern in the aortic orifice, has been put to work in a different haemodynamic environment.
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